Neuromyelitis Optica Spectrum Disorders 2024: Update on Diagnosis and Therapy

This course will focus on an emerging spectrum of antibody-driven CNS autoimmune disorders that attack the brain and spinal cord, Neuromyelitis Optica Spectrum Disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD).  As recent emerging disorders, NMOSD and MOGAD are being recognized as distinct from multiple sclerosis (MS) and other demyelinating neurological disorders.  This distinction is critical not only from a diagnostic standpoint but also from a therapeutic one since treatment of these disorders as multiple sclerosis can do harm and worsen these otherwise distinct entities.

The goal of this course is to increase awareness of NMOSD and MOGAD and facilitate early diagnosis and therapy.

Difficult diagnostic and therapeutic problems exemplified by real-life cases will be presented, including an exchange of information between faculty and attendees with case presentations, dedicated discussions, question and answer sessions and panel discussions.

1. Develop a clinical plan to identify and diagnose early features suggestive of Neuromyelitis Optica Spectrum Disorders (NMOSD) Based on knowledge of the current diagnostic criteria and how those differ from criteria to diagnose MS or other CNS autoimmune disorders.
2. Consider Neuroimmunologic mechanisms of action, the pathogenetic role of compliment, and evidence for efficacy to assess the risk vs benefits of available and pending disease modifying therapy (DMT) for NMOSD.
3. Recognize and differentiate between the clinical presentations of optic neuritis that are more likely to involve anti-MOG antibodies compared to other causes, such as neuromyelitis optica spectrum disorder (NMOSD) or multiple sclerosis.
4. Distinguish the key clinical features that differentiate NMOSD from MOGAD, with a particular focus on the characteristic manifestations and diagnostic criteria of each disorder.

Disclosure and Conflict of Interest Mitigation
All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and mitigated prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.

Cancellation Policy

Cancellations received in writing no less than 30 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to University of [email protected].

University of Miami Healthcare System reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
University of Miami Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Margaritaville Hollywood Beach Hotel
1111 N. Ocean Drive
Hollywood, FL 33019
954-874-4444

Saturday, October 5, 2024